Results 111 to 120 of about 104,562 (257)
Pulmonary Embolism—A Century of Progress
Reviews a century of progress in the diagnosis, prevention, and management of pulmonary embolism; from the first successful surgical embolectomy in 1924 to advanced imaging, pharmacological thromboprophylaxis, and treatment. In the 21st century, advances include catheter‐directed thrombolysis or mechanical thrombectomy under decision‐making guidance of
D. A. Watters
wiley +1 more source
Background: Warfarin requires ongoing monitoring of the International Normalised Ratio (INR). This is because numerous factors influence the response, including drug interactions with commonly-prescribed medications, such as statins.
Siew Teo +13 more
core +1 more source
HeartWare‐BiVAD was associated with more frequent right ventricular cannulation, whereas HM3‐BiVAD demonstrated a trend toward improved survival despite a more severe preimplant clinical profile, suggesting a potential device‐related advantage of HM3 in biventricular support.
Daler Rahimov +10 more
wiley +1 more source
PID and MPC Algorithms for Automatic Warfarin Dosing
reservedAl giorno d’oggi il warfarin è il farmaco anticoagulante più diffuso per il trattamento di pazienti soggetti a rischio tromboembolico. La propensione del sangue a coagulare si misura tramite un parametro, detto INR (International Normalized ...
FENIO, LINDA
core
Among 11,387 patients with acute gastrointestinal bleeding, overlap‐weighted analyses (n = 10,044) found no statistically significant association between direct oral anticoagulant or warfarin use and 30‐day or 1‐year mortality. Haemodynamic shock was associated with 30‐day mortality, whereas age and Internal Medicine ward admission were associated with
Esther Forkosh +5 more
wiley +1 more source
Objective: The ACCP guideline 2008 recommended cessation of warfarin five days before surgery. However, based on the observation of the clinical practice at Siriraj Hospital, we suggested a shorter period of three days before surgery.
Angsu Chartrungsan +12 more
doaj
Background Oral anticoagulants (OAC) can reduce ischemic stroke/systemic embolism (SSE) in patients with non‐valvular atrial fibrillation (AF) while increasing the risk of major bleeding. We aimed to analyze the number needed to treat for the net benefit
Rungroj Krittayaphong +3 more
doaj +1 more source
Warfarin is an anticoagulant that requires INR-based dosage adjustment. Ascorbic acid may impair warfarin effectiveness according to limited literature.
Pingfa Gao +4 more
doaj +1 more source
Characterization of human warfarin reductase
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Simona Sokolová Supervisor: PharmDr. Petra Malátková, Ph.D. Title of diploma thesis: Characterization of human warfarin reductase Warfarin is
Sokolová, Simona
core
Anti-warfarin antibody preparation and its characterization for radioimmunoassay
Anti-warfarin antiserum was prepared in rabbits by immunization with a synthesized warfarin antigen, 4′-azo-warfarin human serum albumin, which possesses two enantiomorphic haptenic sites of warfarin on the molecule.
HIROKO SATOH +2 more
core +1 more source

